| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH9 EPB41L4B CARMIL1 SORBS1 EPB41L3 RTKN KANK4 RACGAP1 AKAP13 | 1.19e-05 | 239 | 121 | 9 | GO:0031032 |
| GeneOntologyBiologicalProcess | cortical granule exocytosis | 3.41e-05 | 2 | 121 | 2 | GO:0060471 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH9 EPB41L4B CARMIL1 SORBS1 EPB41L3 RTKN SHTN1 SPTBN5 SHROOM4 ARHGAP44 KANK4 RACGAP1 AKAP13 BAIAP2 NLRP5 | 7.29e-05 | 803 | 121 | 15 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH9 EPB41L4B CARMIL1 SORBS1 EPB41L3 RTKN SHTN1 SPTBN5 SHROOM4 ARHGAP44 KANK4 RACGAP1 AKAP13 BAIAP2 PARD3 NLRP5 | 8.63e-05 | 912 | 121 | 16 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin filament bundle distribution | 1.02e-04 | 3 | 121 | 2 | GO:0070650 | |
| GeneOntologyCellularComponent | cell cortex | MYH9 RTKN CLIP4 GRIP1 SPTBN5 SHROOM4 FRY AKAP13 UNC13C PARD3 NLRP5 | 1.06e-05 | 371 | 121 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.45e-04 | 18 | 121 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 2.07e-04 | 93 | 121 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYH9 MYO9A KIF26B KRT28 CARMIL1 SHTN1 DCX MEFV CLIP4 GRIP1 SHROOM4 TTLL4 RACGAP1 AKAP13 BAIAP2 | 2.18e-04 | 899 | 121 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | apical junction complex | 3.19e-04 | 158 | 121 | 6 | GO:0043296 | |
| GeneOntologyCellularComponent | cortical granule | 4.91e-04 | 6 | 121 | 2 | GO:0060473 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLT1 MYH9 MYO9A CARMIL1 SORBS1 RTKN SPTBN5 SHROOM4 SH3PXD2A AKAP13 BAIAP2 | 5.24e-04 | 576 | 121 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | actomyosin contractile ring | 6.85e-04 | 7 | 121 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | site of polarized growth | 6.85e-04 | 253 | 121 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 7.34e-04 | 185 | 121 | 6 | GO:0009898 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 9.09e-04 | 8 | 121 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 9.29e-04 | 129 | 121 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | apical cortex | 1.45e-03 | 10 | 121 | 2 | GO:0045179 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.45e-03 | 10 | 121 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | adherens junction | 1.48e-03 | 212 | 121 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | actin filament | 1.61e-03 | 146 | 121 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.23e-03 | 230 | 121 | 6 | GO:0098562 | |
| GeneOntologyCellularComponent | axonal growth cone | 2.25e-03 | 45 | 121 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | cell cortex region | 2.25e-03 | 45 | 121 | 3 | GO:0099738 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH9 EPB41L4B ASH1L SORBS1 EPB41L3 SHROOM4 EFNB2 UBN1 BAIAP2 PARD3 | 2.31e-03 | 591 | 121 | 10 | GO:0005911 |
| GeneOntologyCellularComponent | nuclear pore | 2.83e-03 | 101 | 121 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.89e-03 | 14 | 121 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | contractile ring | 2.89e-03 | 14 | 121 | 2 | GO:0070938 | |
| GeneOntologyCellularComponent | growth cone | 3.05e-03 | 245 | 121 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH9 MYO9A KIF26B KRT28 CARMIL1 SHTN1 DCX MEFV CLIP4 GRIP1 SHROOM4 TTLL4 RACGAP1 AKAP13 BAIAP2 | 3.35e-03 | 1179 | 121 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH9 MYO9A KIF26B KRT28 CARMIL1 SHTN1 DCX MEFV CLIP4 GRIP1 SHROOM4 TTLL4 RACGAP1 AKAP13 BAIAP2 | 3.57e-03 | 1187 | 121 | 15 | GO:0099081 |
| GeneOntologyCellularComponent | distal axon | 3.84e-03 | 435 | 121 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | microtubule | 3.86e-03 | 533 | 121 | 9 | GO:0005874 | |
| Domain | ZnF_C2HC | 4.71e-08 | 55 | 116 | 7 | SM00343 | |
| Domain | Znf_CCHC | 4.71e-08 | 55 | 116 | 7 | IPR001878 | |
| Domain | Zinc_finger_PHD-type_CS | 5.20e-05 | 65 | 116 | 5 | IPR019786 | |
| Domain | Bromodomain | 8.86e-05 | 38 | 116 | 4 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.20e-04 | 41 | 116 | 4 | PS50014 | |
| Domain | BROMO | 1.32e-04 | 42 | 116 | 4 | SM00297 | |
| Domain | Bromodomain | 1.32e-04 | 42 | 116 | 4 | IPR001487 | |
| Domain | - | 1.32e-04 | 42 | 116 | 4 | 1.20.920.10 | |
| Domain | - | RGPD2 EPB41L4B PLEKHA4 APBA1 EPB41L3 RTKN PPP4R3A SPTBN5 RGPD3 AKAP13 | 1.64e-04 | 391 | 116 | 10 | 2.30.29.30 |
| Domain | PH_dom-like | RGPD2 EPB41L4B PLEKHA4 APBA1 EPB41L3 RTKN PPP4R3A SPTBN5 RGPD3 AKAP13 | 3.25e-04 | 426 | 116 | 10 | IPR011993 |
| Domain | ZF_PHD_1 | 3.30e-04 | 96 | 116 | 5 | PS01359 | |
| Domain | AWS | 3.78e-04 | 5 | 116 | 2 | SM00570 | |
| Domain | AWS | 3.78e-04 | 5 | 116 | 2 | PS51215 | |
| Domain | AWS_dom | 3.78e-04 | 5 | 116 | 2 | IPR006560 | |
| Domain | AT_hook | 6.12e-04 | 27 | 116 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 6.12e-04 | 27 | 116 | 3 | IPR017956 | |
| Domain | ZF_DAG_PE_1 | 6.74e-04 | 64 | 116 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 6.74e-04 | 64 | 116 | 4 | PS50081 | |
| Domain | C1 | 7.14e-04 | 65 | 116 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 7.57e-04 | 66 | 116 | 4 | IPR002219 | |
| Domain | GCC2_Rab_bind | 7.87e-04 | 7 | 116 | 2 | IPR032023 | |
| Domain | Rab_bind | 7.87e-04 | 7 | 116 | 2 | PF16704 | |
| Domain | Prefoldin | 1.05e-03 | 72 | 116 | 4 | IPR009053 | |
| Domain | PHD | 1.22e-03 | 75 | 116 | 4 | PF00628 | |
| Domain | Znf_PHD-finger | 1.48e-03 | 79 | 116 | 4 | IPR019787 | |
| Domain | BROMODOMAIN_1 | 1.56e-03 | 37 | 116 | 3 | PS00633 | |
| Domain | - | 1.67e-03 | 10 | 116 | 2 | 1.10.220.60 | |
| Domain | Grip | 2.03e-03 | 11 | 116 | 2 | SM00755 | |
| Domain | GRIP | 2.03e-03 | 11 | 116 | 2 | PF01465 | |
| Domain | Znf_FYVE_PHD | 2.25e-03 | 147 | 116 | 5 | IPR011011 | |
| Domain | PHD | 2.30e-03 | 89 | 116 | 4 | SM00249 | |
| Domain | Ran_BP1 | 2.42e-03 | 12 | 116 | 2 | PF00638 | |
| Domain | GRIP_dom | 2.42e-03 | 12 | 116 | 2 | IPR000237 | |
| Domain | GRIP | 2.42e-03 | 12 | 116 | 2 | PS50913 | |
| Domain | RANBD1 | 2.42e-03 | 12 | 116 | 2 | PS50196 | |
| Domain | Znf_PHD | 2.49e-03 | 91 | 116 | 4 | IPR001965 | |
| Domain | FERM-adjacent | 2.85e-03 | 13 | 116 | 2 | IPR014847 | |
| Domain | FA | 2.85e-03 | 13 | 116 | 2 | SM01195 | |
| Domain | RanBD | 2.85e-03 | 13 | 116 | 2 | SM00160 | |
| Domain | FA | 2.85e-03 | 13 | 116 | 2 | PF08736 | |
| Domain | Ran_bind_dom | 2.85e-03 | 13 | 116 | 2 | IPR000156 | |
| Domain | ZF_PHD_2 | 2.91e-03 | 95 | 116 | 4 | PS50016 | |
| Domain | Post-SET_dom | 4.34e-03 | 16 | 116 | 2 | IPR003616 | |
| Domain | PostSET | 4.34e-03 | 16 | 116 | 2 | SM00508 | |
| Domain | POST_SET | 4.34e-03 | 16 | 116 | 2 | PS50868 | |
| Domain | Ubiquitin-rel_dom | 5.84e-03 | 184 | 116 | 5 | IPR029071 | |
| Pubmed | FAM90A14 FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.49e-23 | 25 | 126 | 12 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 2.97e-19 | 23 | 126 | 10 | 18602769 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SETX SASH1 WEE1 MYO9A KIF26B TEX2 CARMIL1 ZNF629 LMTK2 SORBS1 EPB41L3 RTKN SHTN1 SPICE1 ITPKB GRIP1 FSIP2 SH3PXD2A KIAA1217 NAV2 RACGAP1 AKAP13 MPHOSPH9 BAIAP2 PARD3 AKAP1 OBI1 | 6.56e-18 | 861 | 126 | 27 | 36931259 |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 2.33e-11 | 164 | 126 | 11 | 22967998 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B PDS5B WEE1 CARMIL1 ZMYND8 BAZ1B ZNF217 PPP4R3A SPICE1 UBN1 ATXN7 MKI67 OTUD4 ELF2 ELK3 PARD3 AKAP1 MYBL2 | 4.38e-10 | 774 | 126 | 18 | 15302935 |
| Pubmed | The inĀ vivo Interaction Landscape of Histones H3.1 and H3.3. | PDS5B SETX AHCTF1 INTS1 NSD1 BAZ1B FSIP2 UBE2O UBN1 PHF20L1 MKI67 RACGAP1 ELF2 ANAPC7 PHIP MYBL2 | 7.58e-10 | 608 | 126 | 16 | 36089195 |
| Pubmed | MYH9 SETX MYO9A KIF26B SORBS1 EPB41L3 PPP4R3A MCM3AP NAV2 AKAP13 MPHOSPH9 BAIAP2 OBI1 | 2.69e-08 | 486 | 126 | 13 | 20936779 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETX WEE1 MYO9A ZNF629 BAZ1B TACC2 ZNF217 SORBS1 PPP4R3A UBN1 KIAA1217 MCM3AP OBI1 MYBL2 | 3.25e-08 | 588 | 126 | 14 | 38580884 |
| Pubmed | RGPD2 MYH9 ZMYND8 ZNF217 EPB41L3 SHTN1 GREB1L TLE1 RGPD3 AKAP1 OBI1 MYBL2 | 4.41e-08 | 418 | 126 | 12 | 34709266 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B PDS5B SETX TFAP2E AHCTF1 ZMYND8 NSD1 BAZ1B EPB41L3 UBN1 MKI67 MARF1 RACGAP1 ELF2 PHIP NOL8 MYBL2 | 6.88e-08 | 954 | 126 | 17 | 36373674 |
| Pubmed | RGPD2 MYH9 NSD1 SORBS1 EPB41L3 SHTN1 DCX SPICE1 FRY UBE2O KIAA1217 RGPD3 ARHGAP44 OTUD4 RACGAP1 BAIAP2 PARD3 | 7.86e-08 | 963 | 126 | 17 | 28671696 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYH9 CARMIL1 AHCTF1 ZMYND8 BAZ1B TACC2 EPB41L3 SHTN1 PPP4R3A UBE2O KIAA1217 MKI67 ELF2 PRR14L AKAP1 NOL8 | 2.92e-07 | 934 | 126 | 16 | 33916271 |
| Pubmed | MYH9 EYA4 SETX AHCTF1 TACC2 EPB41L3 MKI67 NAV2 OTUD4 RACGAP1 AKAP13 OBI1 | 3.22e-07 | 503 | 126 | 12 | 16964243 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYH9 EYA4 SETX AHCTF1 ZMYND8 INTS1 ZNF629 NSD1 BAZ1B SKIL UBN1 RGPD3 MKI67 RACGAP1 ELF2 ANAPC7 NOL8 MYBL2 | 1.04e-06 | 1294 | 126 | 18 | 30804502 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPB41L4B MYO9A SOBP CARMIL1 ASH1L ZNF385B SHTN1 ITPKB HIVEP3 EFNB2 ATXN7 SH3PXD2A KIAA1217 ARHGAP44 AKAP13 ASPSCR1 ELK3 BAIAP2 PARD3 | 1.81e-06 | 1489 | 126 | 19 | 28611215 |
| Pubmed | SETX EPB41L4B TEX2 AHCTF1 ASH1L AKNAD1 NSD1 LMTK2 BAZ1B TACC2 DCX SEPSECS KIN TTLL4 OTUD4 PARD3 | 2.05e-06 | 1084 | 126 | 16 | 11544199 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | EPB41L4B ZNF629 EPB41L3 KIN SH3PXD2A MKI67 MARF1 OTUD4 RACGAP1 AKAP13 BAIAP2 ANAPC7 NOL8 | 2.45e-06 | 724 | 126 | 13 | 36232890 |
| Pubmed | CUL4B TEX2 UBE2O KIN TLE1 TTLL4 RACGAP1 AKAP13 PRR14L MPHOSPH9 BAIAP2 AKAP1 MYBL2 | 2.80e-06 | 733 | 126 | 13 | 34672954 | |
| Pubmed | EYA4 SOBP ZMYND8 ZNF629 BAZ1B ZNF217 FHAD1 UBE2O UBN1 ATXN7 TLE1 MKI67 MARF1 OTUD4 RACGAP1 ELF2 ELK3 MYBL2 | 4.16e-06 | 1429 | 126 | 18 | 35140242 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL4B PDS5B RGPD2 WEE1 CARMIL1 AHCTF1 TACC2 SPICE1 KIN PHF20L1 RGPD3 MKI67 RACGAP1 ANAPC7 OBI1 MYBL2 | 4.59e-06 | 1155 | 126 | 16 | 20360068 |
| Pubmed | CUL4B PDS5B MYH9 AHCTF1 INTS1 NSD1 BAZ1B EPB41L3 UBE2O MCM3AP MKI67 PHIP | 4.82e-06 | 653 | 126 | 12 | 22586326 | |
| Pubmed | FAT4 MYH9 SETX EPB41L4B EPB41L3 EFNB2 KIN MKI67 MPHOSPH9 BAIAP2 PARD3 AKAP1 NOL8 | 5.26e-06 | 777 | 126 | 13 | 35844135 | |
| Pubmed | Maternal diabetes alters transcriptional programs in the developing embryo. | 5.46e-06 | 32 | 126 | 4 | 19538749 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.73e-06 | 351 | 126 | 9 | 38297188 | |
| Pubmed | Notch Activation by Shootin1 Opposing Activities on 2 Ubiquitin Ligases. | 7.50e-06 | 11 | 126 | 3 | 28981589 | |
| Pubmed | 8.12e-06 | 75 | 126 | 5 | 25593309 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.54e-06 | 283 | 126 | 8 | 30585729 | |
| Pubmed | Medial epithelial seam cell migration during palatal fusion. | 1.30e-05 | 2 | 126 | 2 | 31264714 | |
| Pubmed | EphrinB2 and GRIP1 stabilize mushroom spines during denervation-induced homeostatic plasticity. | 1.30e-05 | 2 | 126 | 2 | 33789115 | |
| Pubmed | Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers. | 1.30e-05 | 2 | 126 | 2 | 28766905 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18649926 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23892081 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23096218 | ||
| Pubmed | Age-related changes in Ki-67 and DCX expression in the BALB/ c mouse (Mus Musculus) brain. | 1.30e-05 | 2 | 126 | 2 | 30472241 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 11371513 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19710359 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18761331 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 19737411 | ||
| Pubmed | CUL4B WEE1 AHCTF1 ZMYND8 ASH1L ZNF629 BAZ1B EPB41L3 SKIL ATXN7 MCM3AP PARD3 ANAPC7 VPS53 PHIP | 1.33e-05 | 1116 | 126 | 15 | 31753913 | |
| Pubmed | 1.59e-05 | 86 | 126 | 5 | 37253089 | ||
| Pubmed | 1.74e-05 | 222 | 126 | 7 | 37071664 | ||
| Pubmed | SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis. | 2.05e-05 | 15 | 126 | 3 | 24019535 | |
| Pubmed | 2.51e-05 | 16 | 126 | 3 | 29255003 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.59e-05 | 533 | 126 | 10 | 30554943 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | MYH9 TEX2 TACC2 SORBS1 KIAA1217 TTLL4 ELK3 MPHOSPH9 PARD3 MYBL2 | 2.71e-05 | 536 | 126 | 10 | 15840001 |
| Pubmed | MYH9 TEX2 TACC2 SORBS1 KIAA1217 TTLL4 ELK3 MPHOSPH9 PARD3 MYBL2 | 2.80e-05 | 538 | 126 | 10 | 10512203 | |
| Pubmed | 3.64e-05 | 18 | 126 | 3 | 26209645 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.67e-05 | 444 | 126 | 9 | 34795231 | |
| Pubmed | SORBS1 EPB41L3 RTKN SPICE1 GRIP1 SH3PXD2A MPHOSPH9 BAIAP2 PARD3 | 3.79e-05 | 446 | 126 | 9 | 24255178 | |
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 27284123 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 27259241 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 23135572 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 28978486 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 18484747 | ||
| Pubmed | 3.90e-05 | 3 | 126 | 2 | 23045525 | ||
| Pubmed | PDS5B AHCTF1 ZMYND8 ASH1L BAZ1B SKIL HIVEP3 PHF20L1 PITX2 ELF2 DMRT1 MYBL2 | 3.96e-05 | 808 | 126 | 12 | 20412781 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYH9 EPB41L4B CARMIL1 SORBS1 EPB41L3 SHTN1 KIAA1217 NAV2 BAIAP2 PARD3 | 4.23e-05 | 565 | 126 | 10 | 25468996 |
| Pubmed | 4.31e-05 | 19 | 126 | 3 | 32234482 | ||
| Pubmed | 5.13e-05 | 263 | 126 | 7 | 34702444 | ||
| Pubmed | 5.89e-05 | 21 | 126 | 3 | 21451048 | ||
| Pubmed | 5.89e-05 | 21 | 126 | 3 | 32591430 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDS5B MYH9 WEE1 SORBS1 EPB41L3 PPP4R3A LOXHD1 IGHA1 TLE1 OTUD4 RACGAP1 AKAP13 BAIAP2 PARD3 OBI1 | 6.62e-05 | 1284 | 126 | 15 | 17353931 |
| Pubmed | 6.80e-05 | 22 | 126 | 3 | 27717094 | ||
| Pubmed | SRSF2 in Sertoli cells is essential for testicular development and spermatogenesis in mice. | 6.80e-05 | 22 | 126 | 3 | 37039821 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EYA4 SETX ZMYND8 SKIL SEPSECS PHF20L1 TLE1 PITX2 TSHZ1 ANAPC7 OBI1 MYBL2 | 6.94e-05 | 857 | 126 | 12 | 25609649 |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 37875116 | ||
| Pubmed | The ubiquitin-like protein LC3 regulates the Rho-GEF activity of AKAP-Lbc. | 7.78e-05 | 4 | 126 | 2 | 19696020 | |
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 31118423 | ||
| Pubmed | 7.78e-05 | 4 | 126 | 2 | 18205207 | ||
| Pubmed | 7.80e-05 | 23 | 126 | 3 | 28162974 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 MYH9 SETX EPB41L4B KIF26B KRT28 INTS1 FRY LOXHD1 MCM3AP AKAP13 | 7.95e-05 | 736 | 126 | 11 | 29676528 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 8.69e-05 | 497 | 126 | 9 | 36774506 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 8.85e-05 | 123 | 126 | 5 | 26912792 | |
| Pubmed | 1.01e-04 | 25 | 126 | 3 | 12522145 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SCHIP1 WEE1 RTKN BLZF1 SPICE1 SEPSECS KIAA1217 TTLL4 MCM3AP OTUD4 MPHOSPH9 ANAPC7 OBI1 | 1.05e-04 | 1038 | 126 | 13 | 26673895 |
| Pubmed | SETX AHCTF1 ZMYND8 INTS1 NSD1 BAZ1B ZNF217 GREB1L ATXN7 RGPD3 OTUD4 BAIAP2 PARD3 AKAP1 ANAPC7 NOL8 | 1.06e-04 | 1497 | 126 | 16 | 31527615 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B MYH9 SETX MYO9A AHCTF1 BAZ1B EPB41L3 UBN1 MCM3AP MKI67 RACGAP1 AKAP13 PRR14L PARD3 PHIP | 1.18e-04 | 1353 | 126 | 15 | 29467282 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TFAP2E AHCTF1 ASH1L SKIL CREBZF HIVEP3 PITX2 ELF2 TSHZ1 ELK3 DMRT1 MYBL2 | 1.19e-04 | 908 | 126 | 12 | 19274049 |
| Pubmed | ZNF629 EPB41L3 SHTN1 SPICE1 UBE2O UBN1 RACGAP1 ELF2 MPHOSPH9 PHIP | 1.26e-04 | 645 | 126 | 10 | 25281560 | |
| Pubmed | 1.27e-04 | 27 | 126 | 3 | 27178982 | ||
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 27701470 | ||
| Pubmed | The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif. | 1.29e-04 | 5 | 126 | 2 | 9920925 | |
| Pubmed | Ndrg2 expression in neurogenic germinal zones of embryonic and postnatal mouse brain. | 1.29e-04 | 5 | 126 | 2 | 22143493 | |
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 39390582 | ||
| Pubmed | p75NTR prevents the onset of cerebellar granule cell migration via RhoA activation. | 1.29e-04 | 5 | 126 | 2 | 36040414 | |
| Pubmed | 1.29e-04 | 5 | 126 | 2 | 34171797 | ||
| Pubmed | 1.38e-04 | 215 | 126 | 6 | 35973513 | ||
| Pubmed | 1.42e-04 | 28 | 126 | 3 | 30796806 | ||
| Pubmed | 1.56e-04 | 421 | 126 | 8 | 36976175 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.80e-04 | 430 | 126 | 8 | 35044719 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.81e-04 | 77 | 126 | 4 | 24927568 | |
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 24209749 | ||
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 22606329 | ||
| Pubmed | DNA Methyltransferase 1 Is Indispensable for Development of the Hippocampal Dentate Gyrus. | 1.93e-04 | 6 | 126 | 2 | 27251626 | |
| Pubmed | Nav2 hypomorphic mutant mice are ataxic and exhibit abnormalities in cerebellar development. | 1.93e-04 | 6 | 126 | 2 | 21419114 | |
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 23229549 | ||
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 32000863 | ||
| Pubmed | 1.93e-04 | 6 | 126 | 2 | 17567962 | ||
| Pubmed | Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases. | 1.93e-04 | 6 | 126 | 2 | 24019522 | |
| Pubmed | Pitx2 defines alternate pathways acting through MyoD during limb and somitic myogenesis. | 1.93e-04 | 6 | 126 | 2 | 20978076 | |
| Interaction | YWHAH interactions | SETX SASH1 WEE1 MYO9A KIF26B TEX2 CARMIL1 PLEKHA4 ZNF629 LMTK2 SORBS1 EPB41L3 RTKN SHTN1 GRIP1 SH3PXD2A KIAA1217 NAV2 RACGAP1 AKAP13 MPHOSPH9 BAIAP2 PARD3 AKAP1 | 9.71e-09 | 1102 | 114 | 24 | int:YWHAH |
| Interaction | SFN interactions | SASH1 WEE1 MYO9A KIF26B TEX2 CARMIL1 ZNF629 LMTK2 SORBS1 SHTN1 GRIP1 SH3PXD2A NAV2 RACGAP1 AKAP13 MPHOSPH9 BAIAP2 PARD3 OBI1 | 1.13e-08 | 692 | 114 | 19 | int:SFN |
| Interaction | YWHAZ interactions | MYH9 SASH1 WEE1 MYO9A KIF26B TEX2 PLEKHA4 ZNF629 TACC2 SORBS1 EPB41L3 RTKN SHTN1 GRIP1 FSIP2 SH3PXD2A NAV2 OTUD4 RACGAP1 AKAP13 PRR14L MPHOSPH9 BAIAP2 PARD3 | 2.84e-07 | 1319 | 114 | 24 | int:YWHAZ |
| Interaction | YWHAG interactions | SASH1 WEE1 MYO9A KIF26B CARMIL1 PLEKHA4 ZNF629 LMTK2 SORBS1 EPB41L3 RTKN SHTN1 SPICE1 ITPKB GRIP1 SH3PXD2A NAV2 RACGAP1 AKAP13 MPHOSPH9 BAIAP2 PARD3 | 1.65e-06 | 1248 | 114 | 22 | int:YWHAG |
| Interaction | NUP43 interactions | PDS5B SETX AHCTF1 ZMYND8 ASH1L NSD1 FSIP2 PHF20L1 MCM3AP MKI67 MARF1 ELF2 BAIAP2 PHIP MYBL2 | 2.44e-06 | 625 | 114 | 15 | int:NUP43 |
| Interaction | FLOT1 interactions | ABCA1 MYH9 PLEKHA4 LMTK2 SORBS1 KCNB2 EPB41L3 FAM90A1 KIAA1217 OTUD4 ELF2 PARD3 VPS53 | 2.93e-06 | 475 | 114 | 13 | int:FLOT1 |
| Interaction | H3C1 interactions | CUL4B PDS5B FAT4 MYH9 AHCTF1 ZMYND8 INTS1 ASH1L NSD1 BAZ1B GRIP1 UBN1 MKI67 NAV2 RACGAP1 ELF2 PRR14L PHIP | 3.00e-06 | 901 | 114 | 18 | int:H3C1 |
| Interaction | SMC5 interactions | CUL4B PDS5B MYH9 SETX TFAP2E AHCTF1 ZMYND8 PLEKHA4 NSD1 BAZ1B EPB41L3 UBN1 MKI67 MARF1 RACGAP1 ELF2 PHIP NOL8 MYBL2 | 3.21e-06 | 1000 | 114 | 19 | int:SMC5 |
| Interaction | LIN7B interactions | 3.38e-06 | 41 | 114 | 5 | int:LIN7B | |
| Interaction | CBX3 interactions | CUL4B PDS5B AHCTF1 ZMYND8 PLEKHA4 ZNF629 NSD1 BAZ1B ZNF217 UBE2O MKI67 ELF2 PHIP NOL8 MYBL2 | 3.65e-06 | 646 | 114 | 15 | int:CBX3 |
| Interaction | YWHAB interactions | SASH1 WEE1 MYO9A KIF26B PLEKHA4 ZNF629 SORBS1 EPB41L3 RTKN SHTN1 ITPKB GRIP1 SH3PXD2A NAV2 RACGAP1 AKAP13 MPHOSPH9 BAIAP2 PARD3 | 3.92e-06 | 1014 | 114 | 19 | int:YWHAB |
| Interaction | YWHAQ interactions | MYH9 SASH1 WEE1 MYO9A KIF26B PLEKHA4 ZNF629 SORBS1 EPB41L3 RTKN SHTN1 MEFV GRIP1 SH3PXD2A NAV2 RACGAP1 AKAP13 MPHOSPH9 BAIAP2 PARD3 | 4.24e-06 | 1118 | 114 | 20 | int:YWHAQ |
| Interaction | RCOR1 interactions | CUL4B MYH9 ZMYND8 ZNF217 EPB41L3 SHTN1 PPP4R3A SEPSECS MKI67 AKAP1 VPS53 OBI1 PHIP | 4.48e-06 | 494 | 114 | 13 | int:RCOR1 |
| Interaction | H2BC8 interactions | PDS5B MYH9 AHCTF1 ZMYND8 INTS1 ZNF629 NSD1 BAZ1B UBE2O MKI67 RACGAP1 ELF2 PHIP MYBL2 | 4.70e-06 | 576 | 114 | 14 | int:H2BC8 |
| Interaction | SETD1A interactions | 5.60e-06 | 170 | 114 | 8 | int:SETD1A | |
| Interaction | CDC20 interactions | 7.41e-06 | 234 | 114 | 9 | int:CDC20 | |
| Interaction | LYN interactions | MYH9 EPB41L4B KIF26B CARMIL1 PLEKHA4 LMTK2 KCNB2 EPB41L3 EFNB2 IGHA1 KIAA1217 RACGAP1 BAIAP2 PARD3 PHIP | 1.33e-05 | 720 | 114 | 15 | int:LYN |
| Interaction | H3-3A interactions | PDS5B MYH9 AHCTF1 INTS1 ASH1L NSD1 BAZ1B UBN1 PHF20L1 MKI67 RACGAP1 ELF2 ANAPC7 PHIP MYBL2 | 2.12e-05 | 749 | 114 | 15 | int:H3-3A |
| Interaction | KDM1A interactions | MYH9 ZMYND8 PLEKHA4 ZNF217 EPB41L3 SHTN1 BLZF1 SPICE1 GREB1L SEPSECS PHF20L1 KIAA1217 BAIAP2 AKAP1 VPS53 OBI1 MYBL2 | 2.15e-05 | 941 | 114 | 17 | int:KDM1A |
| Interaction | YWHAE interactions | SASH1 MYO9A KIF26B PLEKHA4 ZNF629 TACC2 SORBS1 EPB41L3 RTKN SHTN1 DCX GRIP1 UBE2O SH3PXD2A NAV2 RACGAP1 AKAP13 MPHOSPH9 BAIAP2 PARD3 | 2.34e-05 | 1256 | 114 | 20 | int:YWHAE |
| Interaction | H3C3 interactions | PDS5B SETX AHCTF1 NSD1 BAZ1B FSIP2 UBE2O MKI67 RACGAP1 ELF2 ANAPC7 PHIP | 2.41e-05 | 495 | 114 | 12 | int:H3C3 |
| Interaction | TNRC6A interactions | 3.08e-05 | 280 | 114 | 9 | int:TNRC6A | |
| Interaction | FAM90A26 interactions | 3.17e-05 | 2 | 114 | 2 | int:FAM90A26 | |
| Interaction | ZNF330 interactions | PDS5B ZMYND8 ZNF629 NSD1 BAZ1B UBE2O KIN RACGAP1 ELF2 PHIP NOL8 | 4.58e-05 | 446 | 114 | 11 | int:ZNF330 |
| Interaction | CDC16 interactions | 7.95e-05 | 246 | 114 | 8 | int:CDC16 | |
| Interaction | SMG7 interactions | 8.43e-05 | 319 | 114 | 9 | int:SMG7 | |
| Interaction | PSME3 interactions | MYH9 WEE1 PLEKHA4 FAM90A1 ITPKB UBE2O TTLL4 ELF2 PRR14L PARD3 | 8.85e-05 | 398 | 114 | 10 | int:PSME3 |
| Interaction | NAA40 interactions | MYH9 CARMIL1 AHCTF1 ZMYND8 BAZ1B TACC2 EPB41L3 SHTN1 PPP4R3A UBE2O KIAA1217 MKI67 ELF2 PRR14L AKAP1 NOL8 | 1.24e-04 | 978 | 114 | 16 | int:NAA40 |
| Interaction | PPIL2 interactions | 1.35e-04 | 87 | 114 | 5 | int:PPIL2 | |
| Interaction | LZTS2 interactions | MYH9 MYO9A PTPN22 SORBS1 FAM90A1 CLIP4 KIAA1217 TTLL4 MARF1 MPHOSPH9 PARD3 | 1.56e-04 | 512 | 114 | 11 | int:LZTS2 |
| Interaction | TRIM66 interactions | 1.67e-04 | 205 | 114 | 7 | int:TRIM66 | |
| Interaction | ARHGEF18 interactions | 1.69e-04 | 49 | 114 | 4 | int:ARHGEF18 | |
| Interaction | MEFV interactions | 2.18e-04 | 21 | 114 | 3 | int:MEFV | |
| Interaction | H2BC9 interactions | PDS5B MYH9 ASH1L PLEKHA4 NSD1 BAZ1B ZNF385B ADGRG4 FSIP2 FHAD1 | 2.23e-04 | 446 | 114 | 10 | int:H2BC9 |
| Interaction | INF2 interactions | 2.35e-04 | 288 | 114 | 8 | int:INF2 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.15e-13 | 154 | 126 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 5.79e-11 | 234 | 126 | 11 | chr8p23 |
| GeneFamily | PHD finger proteins | 3.58e-05 | 90 | 75 | 5 | 88 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.05e-04 | 181 | 75 | 6 | 694 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | FAT4 SCHIP1 ABCA1 MYH9 SASH1 ZNF217 SKIL ATP10D SEPSECS EFNB2 PHF20L1 TLE1 KIAA1217 | 3.46e-07 | 504 | 115 | 13 | M2157 |
| Coexpression | WANG_RECURRENT_LIVER_CANCER_UP | 1.61e-06 | 20 | 115 | 4 | M10922 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MYH9 EYA4 SETX SASH1 WEE1 MYO9A ZNF217 SPICE1 ITPKB TLE1 KIAA1217 PITX2 KANK4 NAV2 MPHOSPH9 BAIAP2 PARD3 | 1.96e-06 | 1009 | 115 | 17 | M157 |
| Coexpression | GSE3039_CD4_TCELL_VS_B1_BCELL_UP | 2.94e-06 | 200 | 115 | 8 | M6466 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CUL4B PDS5B SETX MYO9A AHCTF1 BAZ1B EPB41L3 SHTN1 BLZF1 PHF20L1 ARHGAP44 MKI67 OBI1 | 6.33e-06 | 656 | 115 | 13 | M18979 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 7.28e-06 | 300 | 115 | 9 | M8702 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ABCA1 WEE1 INTS1 PTPN22 CREBZF KIN IGHA1 TLE1 ELF2 MPHOSPH9 AKAP1 | 8.07e-06 | 475 | 115 | 11 | M40979 |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 1.30e-05 | 176 | 115 | 7 | M8248 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B SCHIP1 SETX SASH1 AHCTF1 ZMYND8 BAZ1B KIN TLE1 OTUD4 AKAP13 MPHOSPH9 PARD3 PHIP | 2.37e-05 | 856 | 115 | 14 | M4500 |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 2.69e-05 | 197 | 115 | 7 | M9862 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 2.87e-05 | 199 | 115 | 7 | M6443 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN | 2.96e-05 | 200 | 115 | 7 | M9463 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 2.96e-05 | 200 | 115 | 7 | M7915 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | 6.90e-05 | 157 | 115 | 6 | M14242 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | SASH1 EPB41L4B TEX2 NSD1 TACC2 FRY KIAA1217 ELF2 AKAP13 AKAP1 | 1.41e-04 | 542 | 115 | 10 | M19529 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | 1.46e-04 | 180 | 115 | 6 | MM612 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP | 2.26e-04 | 195 | 115 | 6 | M8421 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 2.32e-04 | 196 | 115 | 6 | M9867 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 2.38e-04 | 197 | 115 | 6 | M9916 | |
| Coexpression | HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP | 2.44e-04 | 69 | 115 | 4 | M1319 | |
| Coexpression | HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP | 2.44e-04 | 69 | 115 | 4 | MM1158 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN | 2.45e-04 | 198 | 115 | 6 | M8355 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 2.45e-04 | 198 | 115 | 6 | M8624 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN | 2.45e-04 | 198 | 115 | 6 | M5701 | |
| Coexpression | PEREZ_TP53_TARGETS | ABCA1 TFAP2E EPB41L4B WEE1 KIF26B ASH1L EPB41L3 SPICE1 ITPKB FRY KIN KIAA1217 ARHGAP44 ASPSCR1 BAIAP2 | 2.46e-04 | 1201 | 115 | 15 | M4391 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | CUL4B RGPD2 AHCTF1 CREBZF PPP4R3A ITPKB PHF20L1 RGPD3 MPHOSPH9 | 2.48e-04 | 474 | 115 | 9 | M40991 |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN | 2.52e-04 | 199 | 115 | 6 | M5682 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M9472 | |
| Coexpression | GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M8038 | |
| Coexpression | GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN | 2.58e-04 | 200 | 115 | 6 | M322 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP | 2.58e-04 | 200 | 115 | 6 | M9594 | |
| Coexpression | GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 2.58e-04 | 200 | 115 | 6 | M9554 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.58e-04 | 200 | 115 | 6 | M9889 | |
| Coexpression | GSE17721_CTRL_VS_LPS_1H_BMDC_UP | 2.58e-04 | 200 | 115 | 6 | M3683 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | PDS5B FAT4 ABCA1 EYA4 SETX KIF26B ASH1L NSD1 BAZ1B EPB41L3 SKIL SHTN1 DCX CLIP4 EFNB2 OTUD4 PHIP | 1.52e-06 | 818 | 113 | 17 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | PDS5B ABCA1 EYA4 SETX ASH1L NSD1 BAZ1B EPB41L3 SKIL OTUD4 PHIP | 1.53e-06 | 330 | 113 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.63e-06 | 312 | 113 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | FAT4 ABCA1 MYH9 EYA4 SETX KIF26B BAZ1B EPB41L3 SKIL SHTN1 DCX CLIP4 EFNB2 PITX2 OTUD4 PHIP | 6.86e-06 | 818 | 113 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | FAT4 ABCA1 MYH9 EYA4 SETX KIF26B BAZ1B EPB41L3 DCX EFNB2 KANK4 OTUD4 ELF2 AKAP13 ELK3 | 2.44e-05 | 806 | 113 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | 2.92e-05 | 165 | 113 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 6.57e-05 | 408 | 113 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.14e-05 | 194 | 113 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | SCHIP1 MYH9 EYA4 NSD1 BAZ1B EPB41L3 DCX CREBZF GREB1L KIAA1217 KANK4 OTUD4 ELF2 AKAP13 | 8.40e-05 | 795 | 113 | 14 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 9.57e-05 | 427 | 113 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.47e-04 | 149 | 113 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.60e-04 | 369 | 113 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.82e-04 | 53 | 113 | 4 | gudmap_kidney_P1_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.19e-04 | 385 | 113 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 2.70e-04 | 396 | 113 | 9 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.75e-04 | 397 | 113 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | CUL4B FAT4 KIF26B SOBP EPB41L3 SHTN1 ATP10D GREB1L KIAA1217 RAVER2 KANK4 NAV2 TSHZ1 | 3.22e-04 | 797 | 113 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 3.24e-04 | 406 | 113 | 9 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | FAT4 ABCA1 EYA4 SETX KIF26B NSD1 BAZ1B EPB41L3 SKIL DCX EFNB2 OTUD4 PHIP | 3.58e-04 | 806 | 113 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 3.87e-04 | 416 | 113 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CUL4B SETX WEE1 MYO9A TEX2 ZNF217 EPB41L3 SHTN1 SPICE1 OTUD4 HFM1 NOL8 MYBL2 | 4.22e-04 | 820 | 113 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.65e-04 | 339 | 113 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-08 | 179 | 116 | 8 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-08 | 180 | 116 | 8 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-08 | 186 | 116 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-08 | 193 | 116 | 8 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-08 | 193 | 116 | 8 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-08 | 193 | 116 | 8 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-08 | 193 | 116 | 8 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-08 | 193 | 116 | 8 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-08 | 193 | 116 | 8 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.24e-08 | 193 | 116 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-08 | 194 | 116 | 8 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-08 | 194 | 116 | 8 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.58e-08 | 200 | 116 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.58e-08 | 200 | 116 | 8 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.58e-08 | 200 | 116 | 8 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.58e-08 | 200 | 116 | 8 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.58e-08 | 200 | 116 | 8 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 5.58e-08 | 200 | 116 | 8 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 160 | 116 | 7 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.20e-07 | 170 | 116 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 3.75e-07 | 174 | 116 | 7 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-07 | 177 | 116 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-07 | 181 | 116 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-07 | 183 | 116 | 7 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.47e-07 | 184 | 116 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 185 | 116 | 7 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.67e-07 | 185 | 116 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.88e-07 | 186 | 116 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.88e-07 | 186 | 116 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.09e-07 | 187 | 116 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.32e-07 | 188 | 116 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-07 | 190 | 116 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.02e-07 | 191 | 116 | 7 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-07 | 192 | 116 | 7 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-07 | 192 | 116 | 7 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-07 | 193 | 116 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-07 | 193 | 116 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.53e-07 | 193 | 116 | 7 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.80e-07 | 194 | 116 | 7 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.80e-07 | 194 | 116 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.80e-07 | 194 | 116 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 7.80e-07 | 194 | 116 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.07e-07 | 195 | 116 | 7 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.35e-07 | 196 | 116 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 8.64e-07 | 197 | 116 | 7 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 9.24e-07 | 199 | 116 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 116 | 7 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.56e-07 | 200 | 116 | 7 | a8adf5902540f6bb15b72efbb9c389b59d67e001 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.56e-07 | 200 | 116 | 7 | 3ef7b7728615710c691aed8977e2582f19692cf9 | |
| ToppCell | distal-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.56e-07 | 200 | 116 | 7 | 7a99f28670ffb8ece7873d8a9bcd2a3936d0255d | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.56e-07 | 200 | 116 | 7 | 43bc48413b100a06f8edd9acd812296788fcbf5b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.56e-07 | 200 | 116 | 7 | 7034f57e282982c19c13ee8ab78eabaffa069e30 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.56e-07 | 200 | 116 | 7 | 4d6714d48738cdee7d535923f6dd2431e5304741 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.56e-07 | 200 | 116 | 7 | 707148e01e961097819a05437a842b7d3bf72b0a | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 3.42e-06 | 156 | 116 | 6 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.25e-06 | 162 | 116 | 6 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.53e-06 | 179 | 116 | 6 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.53e-06 | 179 | 116 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 7.77e-06 | 180 | 116 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.77e-06 | 180 | 116 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-06 | 180 | 116 | 6 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-06 | 180 | 116 | 6 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 8.02e-06 | 181 | 116 | 6 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 8.02e-06 | 181 | 116 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.28e-06 | 182 | 116 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 8.81e-06 | 184 | 116 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.81e-06 | 184 | 116 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.09e-06 | 185 | 116 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 9.09e-06 | 185 | 116 | 6 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 9.09e-06 | 185 | 116 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.09e-06 | 185 | 116 | 6 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-06 | 186 | 116 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-06 | 186 | 116 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-06 | 186 | 116 | 6 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.66e-06 | 187 | 116 | 6 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 9.66e-06 | 187 | 116 | 6 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.96e-06 | 188 | 116 | 6 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.96e-06 | 188 | 116 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.96e-06 | 188 | 116 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 9.96e-06 | 188 | 116 | 6 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-05 | 189 | 116 | 6 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.03e-05 | 189 | 116 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 189 | 116 | 6 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.03e-05 | 189 | 116 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-05 | 190 | 116 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 190 | 116 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.06e-05 | 190 | 116 | 6 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 190 | 116 | 6 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 190 | 116 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 190 | 116 | 6 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-05 | 190 | 116 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.06e-05 | 190 | 116 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.09e-05 | 191 | 116 | 6 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.09e-05 | 191 | 116 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-05 | 191 | 116 | 6 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 191 | 116 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.09e-05 | 191 | 116 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.09e-05 | 191 | 116 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | facs-Heart-RV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 191 | 116 | 6 | 84ebb9f8e975acc88aa600c08a8aa791256948a6 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 192 | 116 | 6 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 3.88e-08 | 187 | 115 | 10 | 7080_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.76e-06 | 180 | 115 | 8 | 4541_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 7.04e-06 | 196 | 115 | 8 | 3268_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; PC3; HT_HG-U133A | 7.59e-06 | 198 | 115 | 8 | 4258_DN | |
| Disease | Hepatitis | 1.18e-06 | 22 | 108 | 4 | HP_0012115 | |
| Disease | corpus callosum volume measurement | 1.88e-06 | 100 | 108 | 6 | EFO_0010299 | |
| Disease | uric acid measurement | FAT4 ABCA1 MYO9A CARMIL1 EFCAB13 LMTK2 BAZ1B EPB41L3 CASTOR1 AKAP13 HFM1 | 1.52e-05 | 610 | 108 | 11 | EFO_0004761 |
| Disease | urticaria | 5.19e-05 | 20 | 108 | 3 | EFO_0005531 | |
| Disease | Pontocerebellar hypoplasia type 2 | 1.97e-04 | 6 | 108 | 2 | cv:C2932714 | |
| Disease | cortical thickness | PDS5B EYA4 TACC2 ZNF385B SHTN1 PPP4R3A GRIP1 SEPSECS EFNB2 UBN1 SH3PXD2A NAV2 PARD3 | 2.18e-04 | 1113 | 108 | 13 | EFO_0004840 |
| Disease | orofacial cleft (is_implicated_in) | 2.75e-04 | 7 | 108 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | Cataract | 3.38e-04 | 37 | 108 | 3 | C0086543 | |
| Disease | squamous cell lung carcinoma | 3.61e-04 | 165 | 108 | 5 | EFO_0000708 | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 4.70e-04 | 9 | 108 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | white matter microstructure measurement | 5.93e-04 | 390 | 108 | 7 | EFO_0005674 | |
| Disease | body surface area | 6.04e-04 | 643 | 108 | 9 | EFO_0022196 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 6.46e-04 | 46 | 108 | 3 | EFO_0008003, GO_0097332 | |
| Disease | mean reticulocyte volume | PDS5B MYH9 TFAP2E ZNF217 PPP4R3A KIN PHF20L1 KIAA1217 OTUD4 AKAP13 | 7.13e-04 | 799 | 108 | 10 | EFO_0010701 |
| Disease | neuropsychological test | 8.06e-04 | 197 | 108 | 5 | EFO_0003926 | |
| Disease | brain measurement, neuroimaging measurement | 9.55e-04 | 550 | 108 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Congenital pontocerebellar hypoplasia | 1.01e-03 | 13 | 108 | 2 | C0266468 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 1.17e-03 | 14 | 108 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | thyroid stimulating hormone measurement | 1.23e-03 | 323 | 108 | 6 | EFO_0004748 | |
| Disease | age-related hearing impairment | 1.25e-03 | 324 | 108 | 6 | EFO_0005782 | |
| Disease | response to cranial radiation therapy, short-term memory | 1.40e-03 | 60 | 108 | 3 | EFO_0004335, EFO_0010950 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.54e-03 | 16 | 108 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Pontoneocerebellar hypoplasia | 1.54e-03 | 16 | 108 | 2 | cv:C1261175 | |
| Disease | urate measurement | ABCA1 MYO9A CARMIL1 ASH1L NSD1 LMTK2 BAZ1B EPB41L3 AKAP13 HFM1 | 1.67e-03 | 895 | 108 | 10 | EFO_0004531 |
| Disease | graft-versus-host disease (is_implicated_in) | 1.74e-03 | 17 | 108 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | body fat percentage | 2.15e-03 | 488 | 108 | 7 | EFO_0007800 | |
| Disease | freckles | 2.42e-03 | 20 | 108 | 2 | EFO_0003963 | |
| Disease | Drugs used in diabetes use measurement | 2.51e-03 | 255 | 108 | 5 | EFO_0009924 | |
| Disease | susceptibility to mumps measurement | 2.66e-03 | 75 | 108 | 3 | EFO_0008404 | |
| Disease | Nonsyndromic genetic hearing loss | 2.76e-03 | 76 | 108 | 3 | cv:C5680182 | |
| Disease | pyruvate measurement | 3.10e-03 | 268 | 108 | 5 | EFO_0010117 | |
| Disease | brain connectivity measurement | 3.58e-03 | 400 | 108 | 6 | EFO_0005210 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLLSSPTKDSKPNIS | 441 | Q92667 | |
| ISSSLGKKPSLTSES | 646 | Q9NR48 | |
| PLTSSSAKLPKSLSS | 261 | Q9BZE9 | |
| SSKSTGAISSIPKTT | 1681 | Q8IZF6 | |
| KLLTPSLKSTATSST | 3036 | Q8IZF6 | |
| QKKFPSDLLLTSSSG | 246 | Q8WTX7 | |
| SKTDNSSLSSPLNPK | 321 | Q9UIG0 | |
| LTIKSSDKGSPSQST | 2741 | Q6V0I7 | |
| LPFSGKHSLASISKT | 4376 | Q6V0I7 | |
| LPSSKLKSKTSQLSG | 1021 | O95477 | |
| STSASTRLFGLTKPK | 2766 | Q12802 | |
| KSPSLSSRASAGLNS | 456 | Q8N3C7 | |
| LRKASLSSSSSLGPK | 186 | A6NDY2 | |
| SSLLACGRKSSQTPK | 31 | Q9P241 | |
| PSKASSLSALSLAKD | 191 | Q6VUC0 | |
| LSSPASKTTLHKTGI | 596 | Q9HCJ3 | |
| KPLSSAGKQSQTKSS | 1136 | Q9NTI5 | |
| SSDTKGSPLASISKS | 816 | Q96L73 | |
| GNSTSLPLSRKVLKS | 236 | Q01804 | |
| NSTSSKQTLKTPGKS | 731 | Q9Y2R2 | |
| LSGRQSPSFKLSLSS | 736 | Q6IN85 | |
| SPSFKLSLSSGTKTN | 741 | Q6IN85 | |
| LRKASLSSSSSLGPK | 186 | A6NKC0 | |
| KSSTLGPSALKTIGS | 221 | O60870 | |
| LSKTSKVRPSTGNSA | 76 | Q9UJX3 | |
| LRKASLSSSSSLGPK | 186 | A8MXZ1 | |
| SPGNSSKDLSKTTLV | 411 | Q7Z3Y7 | |
| KLKLPSLLTRGSSST | 646 | O60721 | |
| SSPTTLLATKKNIGR | 361 | Q9H2G9 | |
| SSASALTGLTKRPKL | 66 | Q8N201 | |
| LRKASLSSSSSLGPK | 186 | Q86YD7 | |
| STTKTLSFSTKSLPQ | 1751 | Q2KJY2 | |
| RTGASSLLNKSSPVK | 546 | O60318 | |
| NGLSPKLQLTSKSKS | 71 | Q8IVV2 | |
| SKLSPKSTLSTSSLK | 6696 | Q5CZC0 | |
| LRKTSLSSSSSLGPK | 186 | A8MWA6 | |
| TLSLSTLATPKRSGN | 266 | P52799 | |
| LRKASLSSSSSLGPK | 186 | P0C7W9 | |
| GKQSTKPFDLSSLTS | 106 | Q9GZW8 | |
| SSSLGPKRKALSSTL | 201 | A0A1B0GTH6 | |
| LSSTLLQSKPQKTSS | 211 | A0A1B0GTH6 | |
| STKRKIQSSLSSASP | 706 | Q5W0B1 | |
| IQSSLSSASPSKATK | 711 | Q5W0B1 | |
| SSPGSSSTSLLIKKQ | 721 | Q99550 | |
| KTTSNLLSSKPSLQT | 1431 | Q8IWU2 | |
| TGLLSQSDSKSSKLT | 1286 | P35579 | |
| TTSPSLKSLSLAGNK | 891 | P59047 | |
| ASSSLGENKPRSLKT | 106 | O15553 | |
| SATKPENLSSKTRGS | 411 | P46013 | |
| LRKASLSSSSSLGPK | 186 | P0DV74 | |
| GLKSLNRKSPSHSSS | 441 | Q76FK4 | |
| RSDSSGLTSLKKSPK | 711 | Q76FK4 | |
| SAKLAREKSSSPSGS | 526 | Q3MIN7 | |
| LRKASLSSSSSLGPK | 186 | P0DV73 | |
| LLGSQKSGKLPSSSS | 1241 | Q9C091 | |
| VLSASSSSSKLLKSP | 211 | O15265 | |
| SSKSLRPKESSGNST | 676 | O15265 | |
| LRKASLSSSSSLGPK | 186 | P0DV76 | |
| SSSTRGSKLPLQESK | 1301 | A2PYH4 | |
| LRKASLSSSSSLGPK | 186 | A6NJQ4 | |
| SLSKSPAKLNQSGTS | 1301 | A6NKT7 | |
| DTPGSSKLEKSNLSS | 46 | O95677 | |
| SSKSSQSLLHSKPSG | 1396 | B1AJZ9 | |
| KSSLKGSNPLKSRSL | 701 | Q92953 | |
| SSQDTLRSTKSGPKL | 391 | P0CW27 | |
| ANGTSSSQLSTPKSK | 316 | O43602 | |
| SKTPLTATLSKSGNT | 211 | P01876 | |
| SLSKLSPTSQKGTSS | 351 | Q5T1N1 | |
| LGSTQLLSDKTPSKN | 466 | Q02410 | |
| LKAASSVRSGKNSSP | 331 | Q15723 | |
| LEPLNLSSGSKTKSP | 271 | P41970 | |
| KPQSLKSSTSLSKSL | 406 | Q8IY85 | |
| SLATGAASKSLSLLS | 866 | Q9Y4F3 | |
| IPGKSKTLTSDSSSS | 1676 | Q9Y4F3 | |
| KAGRTALSIALKSPT | 961 | Q5T7N3 | |
| NLSKTSLSPKGVNSL | 311 | Q5VZK9 | |
| LVSRSLPSSSQLKGS | 1146 | Q8WYP5 | |
| PDLSSSSKLTASRKS | 1941 | Q5TBA9 | |
| LRKASLSSSSSLGPK | 186 | A6NIJ5 | |
| KSPISAKSESSTLLS | 766 | A6NE01 | |
| LAINSSSLKGKPLSE | 721 | Q9Y3R0 | |
| LRKASLSSSSSLGPK | 186 | A8MXJ8 | |
| NTSTSTKSLLPKESR | 1166 | Q9ULU4 | |
| PNSSSKSLTKLSPGT | 536 | Q9H329 | |
| PTSAKKRKLNSSSSS | 51 | Q13620 | |
| KLSQKSSSSKLSRSP | 86 | Q9Y2J2 | |
| SLSSSSPISNKSTKA | 336 | Q9Y5R6 | |
| LRKASLSSSSSLGPK | 186 | P0C7X0 | |
| SSAFLKSSSNPIPTK | 1546 | Q5THK1 | |
| SLGLKKSSSLESLQT | 881 | Q8TEW0 | |
| ALLSSTLSSGKARSK | 336 | A8MW92 | |
| LTGGPKRLATKLSSS | 206 | Q9BST9 | |
| LPAKSSLAQLKETGS | 246 | P12757 | |
| ALSLSKSPAKLNQSG | 1291 | P0DJD1 | |
| SCSKSGKPSLSSRLQ | 281 | P0DPB3 | |
| ASTISSLSSLSPKKP | 16 | Q9H4M7 | |
| GNLPLRKLSSSSASS | 591 | P27987 | |
| TAPSNSSSLTLSGIK | 611 | P10244 | |
| LRKASLSSSSSLGPK | 186 | A8MX19 | |
| LRKASLSSSSSLGPK | 186 | A6NNJ1 | |
| LRKASLSSSSSLGPK | 186 | P0C7W8 | |
| LRKASLSSSSSLGPK | 186 | D6RGX4 | |
| TSRSATLGKIPKSSA | 1166 | Q8IVL1 | |
| TLGKIPKSSALVSRS | 1171 | Q8IVL1 | |
| KIPALSPSSGKSSSL | 1801 | Q5T5P2 | |
| SKSLETSSALSPSLK | 1611 | Q7Z333 | |
| TSSALSPSLKNKSKG | 1616 | Q7Z333 | |
| LNKSTSSRSLKSLDP | 456 | A0MZ66 | |
| PLTASNTSLLSSCKK | 631 | Q9ULL8 | |
| AKGLTSASLSTKSFP | 181 | Q99697 | |
| TLTKNTPRFGSKSKS | 601 | Q9H0H5 | |
| RTSTTKSKELSPGSA | 586 | Q17R89 | |
| LRKASLSSSSSLGPK | 186 | P0C7V4 | |
| LGSTAAQSLSPKLKA | 3636 | Q9NRC6 | |
| LSKPKKNISSGSTTS | 306 | Q8N0Z3 | |
| GATLPSALSASKSNL | 251 | Q9UQB8 | |
| NRLLKKDASSSPAST | 276 | Q04724 | |
| PKSLLSKARGIDSSS | 191 | P30291 | |
| SLKQTDPQSSSAKGL | 326 | P0CB48 | |
| SELLTKGSTSKPSSK | 471 | Q8NB66 | |
| SSVLPKASTLSKSSA | 1591 | Q8WWQ0 | |
| SLKSTKSATPNRSLV | 31 | B3KS81 | |
| SLSPRDSKQGSSKSA | 581 | A7XYQ1 | |
| GSSSLSLTRKNSPKS | 646 | Q5TCZ1 | |
| NSPKSGSPKSSSLLK | 656 | Q5TCZ1 | |
| SSSSSLSKTSGDLKP | 706 | Q5TCZ1 | |
| LSGLKRPSSSASTKD | 696 | Q9BX66 | |
| SGSGTSRKKSIPLSI | 506 | Q9C0C9 | |
| SSKPSAKSSLSQISS | 1076 | Q5T1R4 | |
| TKLLAASGSNSPTRS | 6 | Q9NS37 | |
| KASLLSAKSSTEPSL | 741 | O94885 | |
| GSSSASSTLKRTKKP | 2116 | O95359 | |
| KGKLKASSSSQPSSS | 226 | Q569K4 | |
| KILSGNLPKTTTSSG | 511 | Q5VIR6 | |
| KLLTSPSLKPSAVSS | 986 | Q9NPG3 | |
| SGIDSSTLAPSNLKS | 806 | O75362 | |
| PKAAGSSLLNKITNS | 106 | Q9HD40 | |
| ELASSSSKLGLKPAS | 106 | Q8N6K0 | |
| SSQKSPELGKSSSVL | 741 | Q9UEG4 | |
| QGSSLKDLGLKTSSL | 386 | Q8IWB9 | |
| SCLLLTGSSSGSKLK | 16 | P17948 | |
| KSLPVSLTANKATSS | 151 | Q14679 | |
| SLALDLKKSGSTTST | 131 | Q6ZSZ6 | |
| LRKASLSSSSSLGPK | 186 | P0DV75 | |
| SSLKTAGKSEPSSKL | 2401 | B2RTY4 |